FDA
- Marketing authorisation holder: NOVARTIS
- Status: approved
🇺🇸 Deoxycortone Pivalate in United States
Deoxycortone Pivalate (DESOXYCORTICOSTERONE PIVALATE) regulatory status in United States.
Marketing authorisations
FDA
- Application: NDA008822
- Marketing authorisation holder: NOVARTIS
- Local brand name: PERCORTEN
- Indication: INJECTABLE — INJECTION
- Status: approved
Deoxycortone Pivalate in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Hematology approved in United States
Frequently asked questions
Is Deoxycortone Pivalate approved in United States?
Yes. FDA has authorised it; FDA has authorised it.
Who is the marketing authorisation holder for Deoxycortone Pivalate in United States?
NOVARTIS holds the US marketing authorisation.